C4.4A expression was compared with the expression of EpCAM, galectin-3 and CO-029, which have been described as reliable markers in colorectal cancer (Sela et al, 1989; Armstrong and Eck, 2003; Nagy et al, 2003). This evidence concerns the gene EPCAM and colorectal cancer.